Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival
Keyword(s):
2017 ◽
Vol 25
(12)
◽
pp. 2607-2619
◽
Keyword(s):
2018 ◽
Keyword(s):
Keyword(s):